Clinical Trial

The Prevalence of Lower Urinary Tract Symptoms in Individuals With Chronic Obstructive Pulmonary Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated January 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease characterized by airflow limitations and respiratory symptoms due to structural changes in the airways. Common symptoms include dyspnea, chronic cough, and increased sputum production. Respiratory diseases are a risk factor for lower urinary tract symptoms, which can lead to leakage if pelvic floor muscles are weak. Lower urinary tract symptoms are classified into storage, emptying, and post-emptying groups. Current literature on urinary incontinence in COPD patients is limited, and there is a need for further research on the presence and effects of lower urinary system symptoms in individuals with COPD and the level of pelvic floor health knowledge.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-27.
Trial Details
NCT Number NCT06958042
Lead Sponsor Kutahya Health Sciences University
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 30 participants
Start Date 2025-01-06
Primary Completion 2026-01-06 (estimated)
Study Completion 2026-01-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-11